INT46107

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.76
First Reported 1983
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 4
Total Number 4
Disease Relevance 0.55
Pain Relevance 0.38

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

molecular_function (CTAG2) biological_process (CTAG2)
Anatomy Link Frequency
MEF 1
nucleus pulposus 1
CTAG2 (Homo sapiens)
Pain Link Frequency Relevance Heat
tail-flick 1 89.36 High High
analgesia 1 87.76 High High
Intracerebroventricular 1 86.40 High High
Morphine 1 73.68 Quite High
Enkephalin 1 68.00 Quite High
Analgesic 1 61.76 Quite High
Pain 1 25.00 Low Low
Action potential 11 5.00 Very Low Very Low Very Low
midbrain 9 5.00 Very Low Very Low Very Low
tetrodotoxin 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cancer 4 88.16 High High
Severe Combined Immunodeficiency 2 73.88 Quite High
Teratoma 7 72.04 Quite High
Injury 2 50.00 Quite Low
Rheumatoid Arthritis 8 5.00 Very Low Very Low Very Low
Disease 5 5.00 Very Low Very Low Very Low
Neurological Disease 2 5.00 Very Low Very Low Very Low
Low Back Pain 2 5.00 Very Low Very Low Very Low
Loss Of Sense Of Smell 2 5.00 Very Low Very Low Very Low
Parkinson's Disease 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In vivo, a successful outcome is evidence of engraftment of donor-derived cells and their expression of CT2 and CSPG.
Gene_expression (expression) of CT2
1) Confidence 0.76 Published 2009 Journal Spine J Section Body Doc Link 19345615 Disease Relevance 0 Pain Relevance 0
OUTCOME MEASURES: In vitro induction of nucleus pulposus chondrocyte phenotype is measured by the percentage of cells expressing CT2 and CSPG.
Gene_expression (expressing) of CT2 in nucleus pulposus
2) Confidence 0.67 Published 2009 Journal Spine J Section Body Doc Link 19345615 Disease Relevance 0 Pain Relevance 0
Dermorphin (I) and [D-Ala2, Phe3, Gly4, Tyr5, Pro6]-beta c-EP (II) have been synthesized by the solid-phase method (beta c-EP, camel beta-endorphin).
Gene_expression (synthesized) of camel
3) Confidence 0.26 Published 1983 Journal Int. J. Pept. Protein Res. Section Abstract Doc Link 6853023 Disease Relevance 0 Pain Relevance 0.38
hESC lines H9 [30] and CT2 [32], [33], hiPSC lines TZ1 (generated by using the lentiviral vectors), YZ1 and YK26 (generated by using the retroviral vectors) were cultured on irradiated mouse embryonic fibroblast (MEF) cells in hESC medium, i.e., DMEM/F12 containing 20% KnockOut Serum Replacer, 0.1 mM Non-essential Amino Acids, 1 mM L-glutamine (all from Invitrogen), and 0.1 mM ?
Gene_expression (generated) of CT2 in MEF
4) Confidence 0.11 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2912324 Disease Relevance 0.55 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox